HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).

AuthorsMarta Anna Sobas, Natalia Alonso Vence, Jose Diaz Arias, Angeles Bendaña Lopez, Maximo Fraga Rodriguez, Jose Luis Bello Lopez
JournalAnnals of hematology (Ann Hematol) Vol. 89 Issue 2 Pg. 217-9 (Feb 2010) ISSN: 1432-0584 [Electronic] Germany
PMID19636554 (Publication Type: Case Reports, Letter)
Chemical References
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib
Topics
  • Boronic Acids (therapeutic use)
  • Bortezomib
  • Castleman Disease (complications, drug therapy, pathology)
  • Humans
  • Male
  • Middle Aged
  • POEMS Syndrome (complications, drug therapy, pathology)
  • Protease Inhibitors (therapeutic use)
  • Pyrazines (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: